The investment bank adds that company's September-quarter earnings came in line with consensus estimates.
The central bank said such loan products, popularly called 80:20 or 75:25 schemes, are likely to expose the banks as well as their home loan borrowers to additional risks.
The declines also tracked the Indian rupee, which fell to a record low as central bank measures to tighten capital outflows and curb gold imports were seen as unlikely to prop up the currency and could even spark further selling if they spook foreign investors.
Hindustan Unilever shares were up 3.7 per cent at 9.24 am after earlier hitting an all-time high of Rs 632.
Wage hikes and rupee depreciation may affect the business.
The problems are being compounded by perceptions that India is ill suited to defend the currency in the near-term.
FIIs have been strong buyers of shares since last year until a recent streak of selling.
DLF, which builds homes, offices and shopping malls, has lost about 61 per cent of its value since listing on the stock exchange in 2007, underperforming the wider market.
RBI will auction Rs 1,000 crore worth of these bonds next Tuesday.
The company stock ended up 4.49 per cent.
While the country imposed limits, it also eased and simplified other restriction to attract foreign inflows. This is done to plug record current account deficit.
In a landmark judgment that has the potential to change the direction of India's pharmaceutical business, the Supreme Court said on Monday that the drug failed to qualify for a patent according to Indian law.
The buyer received poor investor response to the pricing of the share sale.
Wipro and HCL Technologies among its top picks.
Says the TRC proposal was clumsily worded.
Expected cut in withholding tax for debt investments.
BofA Merrill also upgrades its price objectives for private banks, retaining ICICI Bank Ltd as its top pick, and HDFC Bank Ltd and Axis Bank Ltd as its 'preferred' names.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances